Human MMP-2 Protein, His Tag

Source : 

Human MMP-2, His Tag (MM2-H5225) is expressed from human 293 cells (HEK293). It contains AA Ala 30 - Cys 660 (Accession # AAH02576).

 

Molecule : MMP-2

 

Synonyms : MMP2,CLG4,CLG4A,MMP-II,MONA,TBE-1

 

Format : Powder

 

Category : Enzymes

 

Accession : AAH02576

 

Storage : -20℃

 

Shipping condition : Powder,RT

 

Molecular Weight : 71.8 kDa

 

Characteristics :

This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 71.8 kDa. The protein migrates as 66-71 kDa under reducing (R) condition (SDS-PAGE).

 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.

 

Buffer : 50 mM Tris, 150 mM NaCl, pH8.0

 

Description :

Matrix metalloproteinase-2 (MMP-2) is also known as 72 kDa type IV collagenase, 72 kDa gelatinase, Gelatinase A and CLG4A, which belongs to the peptidase M10A family. MMP-2 / CLG4A contains 3 fibronectin type-II domains and 4 hemopexin-like domains. MMP-2 is produced by normal skin fibroblasts. MMP-2 cleaves the collagen-like sequence Pro-Gln-Gly-|-Ile-Ala-Gly-Gln. MMP2 involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. PEX, the C-terminal non-catalytic fragment of MMP2, posseses anti-angiogenic and anti-tumor properties and inhibits cell migration and cell adhesion to FGF2 and vitronectin.

 

References :

(1) Brooks P.C., et al., 1998, Cell 92:391-400.
(2) Fernandez-Patron C., et al., 1999, Circ. Res. 85:906-911.
(3) Fernandez-Patron C., et al., 2000, Circ. Res. 87:670-676.
(4) Bello L., et al., 2001, Cancer Res. 61:8730-8736.
(5) Lovett D.H., et al., 2012, PLoS ONE 7:E34177-E34177.